Thyroid Cancer News and Research

Latest Thyroid Cancer News and Research

Also in global health news: Nuclear accidents; measles outbreak in Europe; funding shortfall in Zimbabwe; drinking water in Pakistan; agricultural development in S. Asia

The world must prepare for more major nuclear accidents, U.N. Secretary-General Ban Ki-moon said on Wednesday at a Kiev conference marking the explosion of a reactor at Ukraine's Chernobyl nuclear reactor 25 years ago, the Associated Press reports.

22 Apr 2011

Study finds minimally invasive thyroid surgery effective in pediatric patients

Surgical approaches that reduce incision size and recovery time from thyroid surgery work well in children, physician-scientists report.

15 Apr 2011

Research on rare cancers

A cancer diagnosis can be a life-changing event. Many questions arise, with one of the first being, "Where should I be treated?" Patients diagnosed with rare cancers may have difficulty finding a physician knowledgeable in treating their type of cancer.

11 Apr 2011

New ATA recommendations on outpatient 131I therapy aim to treat thyroid cancer

New recommendations from the American Thyroid Association on outpatient radioiodine treatment aim to minimize unintended radiation exposure and maximize the safety of patients, their families, and the public.

8 Apr 2011

AstraZeneca's vandetanib receives FDA approval in medullary thyroid cancer

AstraZeneca today announced that the U.S. Food and Drug Administration approved the orphan drug vandetanib for the treatment of medullary thyroid cancer that cannot be removed by surgery or that has spread to other parts of the body.

7 Apr 2011

VBL's VB-111 preclinical data against metastatic cancer presented at AACR meeting

VBL Therapeutics, a clinical-stage biotechnology company committed to the development of novel treatments for immune-inflammatory diseases and cancer, today announced preclinical data demonstrating VB-111's potential utility as a targeted cancer treatment.

7 Apr 2011

AstraZeneca receives FDA approval for vandetanib to treat medullary thyroid cancer

The U.S. Food and Drug Administration today approved vandetanib to treat adult patients with late-stage (metastatic) medullary thyroid cancer who are ineligible for surgery and who have disease that is growing or causing symptoms.

7 Apr 2011

Asuragen launches InformThyroid, a panel of molecular markers

Asuragen, Inc. announced today the launch of Inform™Thyroid, a panel of molecular markers used on Fine Needle Aspirates (FNA) of thyroid nodules to aid physicians in the management of thyroid cancer.

6 Apr 2011

Americans concerned about thyroid cancer development from mammography

Some Americans have expressed concern, due to an erroneous media report, that the small amount of radiation a patient receives from a mammogram may significantly increase the likelihood of developing thyroid cancer. This concern simply is not supported in scientific literature.

6 Apr 2011

VBL's VB-111 preclinical data against metastatic cancer to be presented at AACR meeting

VBL Therapeutics, a clinical-stage biotechnology company committed to the development of novel treatments for immune-inflammatory diseases and cancer, today announced two upcoming presentations of preclinical data from the company's VB-111 program at the American Association for Cancer Research 102nd Annual Meeting.

1 Apr 2011

Iodine 131 exposure during childhood increases risk of developing thyroid cancer

Alan H. Lockwood, MD, professor of neurology and nuclear medicine in the University at Buffalo's School of Medicine and Biomedical Sciences calls the Japanese Health Ministry's advice not to give tap water to infants "prudent."

24 Mar 2011

WHO concerned about radiation levels in food near damaged Japanese nuclear plant

A WHO spokesperson "said on Monday that the detection of radiation in food after an earthquake damaged a Japanese nuclear plant was a more serious problem than had first expected," Reuters reports.

22 Mar 2011

Researchers discover 'broad spectrum' cancer suppressor gene

Portuguese researchers have discovered a "broad spectrum" cancer suppressor gene - called LRP1B - which acts by removing proteins crucial for cancer development from the tumour environment. The fact that LRP1B does not act on the tumour itself (in this study thyroid tumours) but, instead, on molecules which are known to be important to many different cancers is what makes it so interesting.

21 Mar 2011

Experts issue joint statement to help Americans understand radiation-related health risks

The growing concern surrounding the release of radiation from an earthquake and tsunami-stricken nuclear complex in Japan has raised fears of radiation exposure to populations in North America from the potential plume of radioactivity crossing the Pacific Ocean.

19 Mar 2011

Nukepills.com donates 50,000 potassium iodide tablets to Tokushukai Hospital in Tokyo

Approximately 50,000 potassium iodide tablets have been donated by Nukepills.com to Tokushukai Hospital in Tokyo, Japan for immediate distribution to those affected by Japan's nuclear reactor crisis.

16 Mar 2011

Nuclear fallout-related health fears rise in Japan

Concerns regarding health risks "rose dramatically in Japan Tuesday" after officials said more radiation was released at a nuclear power plant that was damaged in the tsunami, the Associated Press reports. In an address to the nation, Prime Minister Naoto Kan said radiation had been emitted from four reactors. "The level seems very high, and there is still a very high risk of more radiation coming out," he said.

16 Mar 2011

WHO reports on risk from radiation exposure, Humanitarian Assistance arrives in Japan following earthquake

The WHO on Saturday said the public health risk of a radiation leak resulting from earthquake damage at a nuclear reactor site in Japan "appeared to be 'quite low' but the WHO network of medical experts was ready to assist if requested," Reuters reports.

15 Mar 2011

EpiCept 2010 fourth quarter net loss is $0.06 per share

EpiCept Corporation today announced operating and financial results for the fourth quarter and full year ended December 31, 2010, and provided an update on its key business initiatives.

24 Feb 2011

2011 Clinical Congress of American College of Surgeons to take place in October, in San Francisco

The 2011 Clinical Congress of the American College of Surgeons—one of the largest international meetings of surgeons in the world—will convene October 23-27, 2011, in San Francisco, CA. The San Francisco Hilton will serve as the headquarters hotel for the meeting, and the Moscone Convention Center will house the scientific panel sessions and courses, as well as all scientific and technical exhibits.

19 Feb 2011

Registration opens for The Endocrine Society's 2011 annual meeting in Boston

Media registration opens today for The Endocrine Society's 93rd Annual Meeting & EXPO taking place in Boston, MA on June 4-7, 2011. ENDO 2011 promises to be an engaging and informative opportunity for journalists to learn about the latest research in obesity, endocrine disrupters, diabetes, growth hormones, sex hormones, thyroid cancer and much more.

17 Feb 2011

Thyroid Cancer News and Research

Latest Thyroid Cancer News and Research

Also in global health news: Nuclear accidents; measles outbreak in Europe; funding shortfall in Zimbabwe; drinking water in Pakistan; agricultural development in S. Asia

Study finds minimally invasive thyroid surgery effective in pediatric patients

Research on rare cancers

New ATA recommendations on outpatient 131I therapy aim to treat thyroid cancer

AstraZeneca's vandetanib receives FDA approval in medullary thyroid cancer

VBL's VB-111 preclinical data against metastatic cancer presented at AACR meeting

AstraZeneca receives FDA approval for vandetanib to treat medullary thyroid cancer

Asuragen launches InformThyroid, a panel of molecular markers

Americans concerned about thyroid cancer development from mammography

VBL's VB-111 preclinical data against metastatic cancer to be presented at AACR meeting

Iodine 131 exposure during childhood increases risk of developing thyroid cancer

WHO concerned about radiation levels in food near damaged Japanese nuclear plant

Researchers discover 'broad spectrum' cancer suppressor gene

Experts issue joint statement to help Americans understand radiation-related health risks

Nukepills.com donates 50,000 potassium iodide tablets to Tokushukai Hospital in Tokyo

Nuclear fallout-related health fears rise in Japan

WHO reports on risk from radiation exposure, Humanitarian Assistance arrives in Japan following earthquake

EpiCept 2010 fourth quarter net loss is $0.06 per share

2011 Clinical Congress of American College of Surgeons to take place in October, in San Francisco

Registration opens for The Endocrine Society's 2011 annual meeting in Boston

CellVoyant's AI-Powered Vision for the Future of Cell Therapy

Scalable, Smart, and Accessible: The Future of Lab Automation

Healthy Beginnings, Hopeful Futures: A Conversation with WHO’s Dr. Allotey

Thyroid Cancer News and Research

Latest Thyroid Cancer News and Research

CellVoyant's AI-Powered Vision for the Future of Cell Therapy

Scalable, Smart, and Accessible: The Future of Lab Automation

Healthy Beginnings, Hopeful Futures: A Conversation with WHO’s Dr. Allotey

Newsletters you may be interested in